床旁超声引导复苏对休克患者临床结局的影响:系统评价与Meta分析
该系统评价与Meta分析纳入18项随机对照试验,评估床旁超声(POCUS)引导复苏对休克成人患者临床结局的影响。POCUS对医生静脉输液和血管活性药物处方计划有轻微影响(中等确定性),但对实际输液或正性肌力药物给药几乎无改变。POCUS可能减少诊断性超声心动图数量(中等确定性),对CT扫描数量可能无影响(低确定性)。POCUS引导复苏可能降低28天死亡率(RR 0.88;95%CI 0.78-0.99)、缩短血管活性药物使用时间(均数差-0.73天;95%CI -1.16至-0.30)、降低肾替代治疗需求(RR 0.80;95%CI 0.63-1.02)并改善乳酸清除(高确定性)。对ICU或住院率、ICU及住院时长、机械通气需求可能几乎无差异(低至中等确定性)。
要点
- POCUS引导复苏可能降低休克患者28天死亡率(RR 0.88;95%CI 0.78-0.99,低至中等确定性证据)。
- POCUS引导复苏可能缩短血管活性药物使用时间(均数差-0.73天;95%CI -1.16至-0.30)。
- POCUS引导复苏可能降低肾替代治疗需求(RR 0.80;95%CI 0.63-1.02)并改善乳酸清除(高确定性证据)。
- POCUS对医生静脉输液和血管活性药物处方计划有轻微影响(中等确定性),但对实际输液或正性肌力药物给药几乎无改变。
- POCUS可能减少诊断性超声心动图数量(中等确定性),对CT扫描数量可能无影响(低确定性)。
适用人群与场景
- 成人休克患者,纳入随机对照试验中评估POCUS引导复苏的研究人群
研究设计与关键结果
- 研究设计:系统评价与Meta分析,纳入18项随机对照试验(RCT),检索MEDLINE、Embase及未发表来源,时间自建库至2023年12月。
- POCUS对医生静脉输液和血管活性药物处方计划有轻微影响(中等确定性),但对实际静脉输液给药(低至高确定性)或正性肌力药物给药(高确定性)几乎无改变。
- POCUS可能对CT扫描数量无改变(低确定性),但可能减少诊断性超声心动图数量(中等确定性)。
- POCUS引导复苏可能降低28天死亡率(RR 0.88;95%CI 0.78-0.99)、缩短血管活性药物使用时间(均数差-0.73天;95%CI -1.16至-0.30)、降低肾替代治疗需求(RR 0.80;95%CI 0.63-1.02)(低至中等确定性证据),并改善乳酸清除(高确定性证据)。
- POCUS引导复苏对ICU或住院入院率、ICU及住院时长、机械通气需求可能几乎无差异(低至中等确定性证据)。
- 对急性肾损伤风险及机械通气或肾替代治疗持续时间的影响不确定(极低确定性证据)。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入18项随机对照试验。
- 证据确定性:从高确定性到极低确定性不等,具体各结局的确定性等级见results。
- 局限:由于缺乏足够证据,无法探讨操作者能力阈值、POCUS扫描频率和时机如何影响患者结局。
对床旁实践的改变
- POCUS引导复苏在休克患者中可能带来重要的患者和卫生系统获益(作者结论)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the impact of point-of-care ultrasound (POCUS)-guided resuscitation on clinical outcomes in adult patients with shock.
DATA SOURCE: We searched MEDLINE, Embase, and unpublished sources from inception to December 2023.
STUDY SELECTION: We included randomized controlled trials (RCTs) that examined the use of POCUS to guide resuscitation in patients with shock.
DATA EXTRACTION: We collected data regarding study and patient characteristics, POCUS protocol, control group interventions, and outcomes.
DATA SYNTHESIS: We identified 18 eligible RCTs. POCUS slightly influences physicians' plans for IV fluid (IVF) and vasoactive medication prescription (moderate certainty), but results in little to no changes in the administration of IVF (low to high certainty) or inotropes (high certainty). POCUS may result in no change in the number of CT scans performed (low certainty) but probably reduces the number of diagnostic echocardiograms performed (moderate certainty). POCUS-guided resuscitation probably reduces 28-day mortality (relative risk [RR] 0.88; 95% CI, 0.78-0.99), the duration of vasoactive medication (mean difference -0.73 d; 95% CI, -1.16 to -0.30), and the need for renal replacement therapy (RRT) (RR 0.80; 95% CI, 0.63-1.02) (low to moderate certainty evidence), and lactate clearance (high certainty evidence). POCUS-guided resuscitation may results in little to no difference in ICU or hospital admissions, ICU and hospital length of stay, and the need for mechanical ventilation (MV) (low to moderate certainty evidence). There is an uncertain effect on the risk of acute kidney injury and the duration of MV or RRT (very low certainty evidence).
CONCLUSIONS: POCUS-guided resuscitation in shock may yield important patient and health system benefits. Due to lack of sufficient evidence, we were unable to explore how the thresholds of operator competency, frequency, and timing of POCUS scans impact patient outcomes.
参考来源
- Basmaji J, Arntfield R, Desai K, et al. The Impact of Point-of-Care Ultrasound-Guided Resuscitation on Clinical Outcomes in Patients With Shock: A Systematic Review and Meta-Analysis. Crit Care Med. 2024. PMID: 39298556. doi:10.1097/CCM.0000000000006399
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。